AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

CDC recommends resumption of third dose of Prevnar.

Vaccine Weekly

| August 04, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 AUG 4 - (NewsRx.com & NewsRx.net) -- The Centers for Disease Control and Prevention (CDC) has issued an updated recommendation that all healthy children under 24 months of age should receive at least 3 doses of Prevnar, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein).

According to the company, Prevnar is the first and only vaccine approved to help prevent invasive pneumococcal disease (IPD) in young children.

Routinely, Prevnar is approved to be given in a 4-dose series at 2, 4, 6, and 12-15 months of age. However, in response to a shortage of vaccine, the CDC had issued recommendations earlier this year that healthcare providers temporarily suspend the third and fourth doses for healthy children. In the announcement, those recommendations have been revised to reinstate administration of the third ...

Related articles from newspapers, magazines, journals, and more
Prevnar Voted for Inclusion in Vaccines for Children Program.
Newspaper article from: Vaccine Weekly July 5, 2000 700+ words
...announced that its vaccine Prevnar has been included in...billion annually. Prevnar targets the seven serotypes...article was prepared by Vaccine Weekly editors from staff...Copyright 2000, Vaccine Weekly via NewsRx.com.
FDA Grants Priority Review Status to Prevnar 13 Marketing Application.
Newspaper article from: Vaccine Weekly May 20, 2009 700+ words
...the scientific foundation of Prevnar, is designed to provide protection...pneumococcal disease." The Prevnar 13* submission to the FDA...than 40 countries worldwide. Prevnar 13 also is being studied in...This article was prepared by Vaccine Weekly editors from staff and other...
Wyeth Provides Regulatory Update on Prevnar 13* in the United States.
Newspaper article from: Vaccine Weekly August 26, 2009 700+ words
...burden of invasive disease. Prevnar has been available in the...distributed worldwide. The Prevnar 13 submission is based on...regulatory applications for Prevnar 13 in more than 50 countries...This article was prepared by Vaccine Weekly editors from staff and other...
Parents encouraged to schedule missed vaccine doses of Prevnar for children.
Newspaper article from: Vaccine Weekly October 20, 2004 700+ words
...recommended resumption of the third Prevnar dose. With this updated announcement...first appearance of symptoms. Prevnar has shown that it can effectively...yet received any doses of Prevnar, and then children older...This article was prepared by Vaccine Weekly editors from staff and ...
CDC recommends return to full four-dose series of Prevnar.
Newspaper article from: Vaccine Weekly October 13, 2004 700+ words
...to 33.6 per 100,000. Prevnar is indicated for active immunization...with all vaccines, including Prevnar. Hypersensitivity to any...contraindication to its use. Prevnar does not provide 100% protection...This article was prepared by Vaccine Weekly editors from staff and other...
Health groups reinstate recommendation for third dose of pediatric Prevnar.
Newspaper article from: Vaccine Weekly August 4, 2004 700+ words
...conjugate vaccine (PCV7, trade name Prevnar) administered to healthy children...children. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
CDC recommends suspension of third and fourth doses of Prevnar.
Newspaper article from: Vaccine Weekly March 24, 2004 700+ words
...markets PCV7 under the trade name Prevnar. "CDC is concerned anytime children...infections. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
FDA GRANTS PRIORITY REVIEW STATUS TO PREVNAR 13 MARKETING APPLICATION.
News wire article from: AsiaPulse News May 8, 2009 700+ words
...PR34571 FDA Grants Priority Review Status to Prevnar 13 Marketing Application COLLEGEVILLE...Biologic License Application (BLA) for Prevnar 13*, Pneumococcal 13-valent Conjugate...seeking an indication in the U.S. for Prevnar 13 for the prevention of invasive pneumococcal...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA